Ibuprofen lysine

Drug Profile

Ibuprofen lysine

Alternative Names: Ibuprofen lysinate - Recordati Rare Diseases; NeoProfen; Pedea

Latest Information Update: 28 Jul 2015

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Farmacon-IL
  • Developer Nycomed Russia; Orphan Europe; Recordati Rare Diseases
  • Class Antirheumatics; Basic amino acids; Nonsteroidal anti-inflammatories; Phenylpropionates
  • Mechanism of Action Cyclooxygenase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Patent ductus arteriosus
  • New Molecular Entity No

Highest Development Phases

  • Marketed Patent ductus arteriosus

Most Recent Events

  • 30 Apr 2015 Launched for Patent ductus arteriosus (In neonates) in Greece (IV)
  • 03 Feb 2015 Launched for Patent ductus arteriosus (In neonates) in Austria (IV)
  • 11 Nov 2014 Launched for Patent ductus arteriosus (In neonates) in Portugal (IV)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top